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 1 
Jenifer Turriziani 
Designer Babies: The Need for Regulation on the Quest For Perfection 
Imagine a society where the ability to create the “perfect child” is a possibility. With 
recent advances in reproductive medicine, parents may one day be able to customize their child’s 
embryos. In 2004 the term “designer baby” was added to the Oxford English Dictionary, where it 
is defined as “a baby whose genetic makeup has been selected in order to eradicate a particular 
defect, or to ensure that a particular gene is present.”1 At this time, the creation of designer 
babies is not yet possible. However, in the future by using Preimplantation Genetic Diagnosis 
(PGD) in conjunction with In Vitro Fertilization (IVF) doctors may have the ability to create 
“designer babies.”  
Assisted Reproductive Technologies (ART), such as IVF and PGD, are most often 
enlisted by infertile couples. PGD can determine which embryos are affected by which genetic 
conditions before implantation. This process ensures that only embryos that test clear of 
inheritable diseases are transferred to the uterus using IVF. While those that carry the harmful 
genes will be discarded prior to implantation. Currently, PGD and IVF have been used to prevent 
couples from giving birth to a child afflicted with genetic disease. This has created many 
concerns surrounding the possibility of these techniques being used to hand select certain genetic 
traits for non-therapeutic reasons. As a result, fertile couples may begin to undergo treatments as 
ART increases the ability to control offspring’s genetic traits prior to fertilization.  
While there are numerous positive aspects of PGD, it is necessary to consider the many 
ethical implications of using such techniques for non-therapeutic purposes. One can only wonder 
what will happen to society when it becomes possible for parents to screen embryos and hand 
                                                        
1
 Designer Baby Definition, OXFORD DICTIONARY, http://www.oxforddictionaries.com/us/definition/american_ 
english/designer-baby dictionary (last visited Nov. 20, 2013). 
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pick genes for their children from an enormous range of attributes including gender, hair color, 
eye color, height, weight, intellect, personalities, athletic ability or musical talent. At present, 
neither state nor federal law regulates PGD; therefore guarding against the possible exploitation 
and objectification of children is a major concern for the future.
2
  
The ethical and social concerns regarding the expansion of PGD demonstrate the 
necessity for oversight by the United States government. PGD may be a beneficial procedure but 
when considering its ability to select for cosmetic genetic traits, it becomes evident the potential 
for manipulation requires the government to regulate these parents on their question for 
perfection.  
This paper will begin by outlining the current methods of ART, including IVF and PGD. 
Section II will illustrate the benefits of using ART exclusively for medical purposes for both 
early and late onset genetic disorders. The therapeutic uses of PGD will be distinguished from 
the non-therapeutic uses. Section III will explore the various social, ethical and legal questions 
regarding PGD. Specifically, this section will examine such dilemmas as sexism, autonomy, 
legal liability issues, distributive justice concerns, genetic elimination, and discrimination in the 
context of selecting for genetic traits. Section IV will discuss the need for oversight of ART by 
the United States government to prevent children from becoming objects and commodities.  
I. Assisted Reproductive Technology’s Creation of Designer Babies 
Today nearly three out of every 100 babies born in the United States are the product of an 
assisted conception.
3
 Assisted Reproductive Technologies (ART) encompasses a range of 
fertility therapies, where the egg and sperm are manipulated to achieve pregnancy. These 
procedures are primarily used as fertility treatments.  However, PGD and IVF may be used by 
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fertile couples for genetic reasons. IVF consists of surgically removing eggs from a woman’s 
ovaries, fertilizing the egg outside the body and then transferring the fertilized egg back into the 
woman’s uterus. PGD is a process that can analyze the genetic make-up of the embryos created 
through IVF before implantation in utero. Together these two procedures can be used to 
genetically engineer a designer baby.    
A. Assisted Reproductive Technologies 
ART consists of numerous methods that are usually combined for the purpose to aid in 
achieving pregnancy by artificial or partially artificial means.
4
 ART enables pregnancy without 
sexual intercourse by surgically removing the eggs from the woman ovaries and fertilizing them 
in the laboratory.
5
 ART has been used in the United States since 1981 as a means to help women 
become pregnant.
6
 
In the past decade, many ART techniques have gained rapid acceptance in the medical 
community and have contributed to over five million births worldwide.
7
 ART is most often used 
to help infertile couples conceive a child. However, with the advancements in reproductive 
medicine these methods could eventually be combined to manipulate the embryo to the point of 
customization. Many more couples will begin to use ARTs for these genetic possibilities. This 
paper will focus on those methods, including IVF and PGD.  
B. In-Vitro Fertilization 
IVF is a process that ultimately fertilizes the egg with the sperm in a laboratory.
8
 IVF 
involves manipulating biological events that occur within a woman's body.
9
 The process begins 
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by promoting ovulation. Normally a woman only produces one egg a month, however fertility 
drugs create an increase in production.
10
 Researchers have found that by administering certain 
hormones, it is possible to cause several follicles to mature, thereby causing the woman's body to 
produce a larger number of eggs.
11
 After around two weeks of daily hormone injections and 
blood tests the doctors remove the eggs.
12
 This second step is known as egg retrieval. This can be 
done either by a laparoscopic procedure or by an ultrasound procedure.
13
 In either scenario a 
minor surgery, called follicular aspiration, is done to remove the eggs from the woman’s 
ovaries.
14
 A thin needle is inserted through the vagina and into the ovary; the needle is connected 
to a suction device, which pulls the eggs and fluid out of each follicle.
 15
 The procedure is then 
repeated on the other ovary.
 16
 By increasing the number of eggs produced this allows more eggs 
to be collected during the procedure, increasing the chance of a successful pregnancy.  
Following the removal of the eggs, they are taken to the laboratory, where they are 
combined with the sperm.
17
 If there is no problem with the sperm, a process known as 
insemination takes places and the sperm and egg are combined in a petri dish.
18
 If sperm 
parameters are abnormal doctors usually use a process known as intracytoplasmic sperm 
injection (ICSI) to directly inject a single sperm into the egg to increase the chances of success.
19
 
Around 16-18 hours after insemination or ICSI, fertilization is assessed.
20
  Once fertilization 
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occurs and the fertilized ova have been allowed to incubate or grow for approximately 48 to 72 
hours, doctors transfer the fertilized egg into the uterus in the hopes of achieving a successful 
pregnancy.
21
 The entire process takes around two to three days.
22
  
C. Preimplantation Genetic Diagnosis  
PGD is a technique used to identify genetic defects in embryos, which are created 
through IVF.
23
  Based on the fact that one or both parents have that known abnormality, PGD 
will be used to test an embryo to determine if it also carries a genetic abnormality.
24
 PGD dates 
back to 1968, when it was first successfully used on rabbit embryos.
25
 By 1989 the first 
unaffected child was born using PGD to test for an X-linked disorder.
 26
 Throughout the 1990s, 
PGD was used to screen for severe, irreversible, genetic conditions.
27
 As of today, PGD is 
available for most known genetic conditions.
28
 
The PGD process begins after the IVF process of fertilization. Embryos must be grown in 
the laboratory for about two to three days and divide into around eight cells before PGD 
treatment can begin.
29
 When the embryos are ready an embryologist removes a single blastomere 
from the developing embryo for genetic evaluation.
 30
 DNA is extracted from the blastomere, and 
tested for chromosomal abnormalities or genetic mutations.
31
 Genetic evaluation is performed 
using polymerase chain reaction (PCR), or fluorescence in situ hybridization (FISH), depending 
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 6 
on the genetic condition being studied.
32
 Cells from the embryo are tested to see if the embryo 
contains genetic conditions. A diagnosis is typically obtained within 24 hours, and then only the 
unaffected embryos are transferred into the woman's uterus, in hopes of developing into a 
successful pregnancy.
33
  
PGD is used to determine genetic defects in embryos.
34
 This technology when combined 
with IVF can prevent implantation of embryos that contain genetic diseases or other undesirable 
traits. After the embryos that carry the genetic diseases or other undesirable traits are discarded, 
the healthy embryos, those that are free of disease, will be implanted into the woman’s uterus.35  
Unfortunately, there are some risks associated with PGD. Even after a successful 
procedure pregnancy is not a guarantee. The probability of getting pregnant from a PGD and IVF 
treatment is low.
36
 This is for two reasons: a relatively large number of embryos found maybe 
abnormal, thus leaving only a few or no healthy embryos for transfer and the PGD procedure 
itself may damage the embryo.
37
 Therefore, in both circumstances there are fewer embryos left 
for implantation.
38
 This results in fewer embryos to fertilize which decreases the chances of 
pregnancy.  
II. Benefits of PGD Exclusively for Therapeutic and Medical Purposes 
PGD is currently used to analyze embryos created through IVF to avoid transferring to 
the mother's uterus an embryo affected by a mutation or chromosomal abnormality.
39  
Since PGD 
can prevent genetic conditions in future children, PGD reduces the chance that the parents will 
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be faced with a difficult decision of whether to terminate the pregnancy. Therefore, PGD has 
been widely accepted for its therapeutic uses, which include selection against serious early-onset 
illnesses, and late-onset disorders. 
A. Early Onset Genetic Diseases  
IVF and PGD technologies are most commonly used to screen for particular diseases and 
select against implantation of any embryo with a given genetic condition. PGD has the ability to 
diagnose many severe genetic disorders including, but not limited to, Cystic fibrosis, Tay-Sachs 
disease, Duchenne's muscular dystrophy, Fragile X syndrome, Down syndrome, and even some 
cancer genes.
40
 The benefit of PGD in comparison to other existing prenantal screening is the 
embryos are scanned for genetic conditions prior to implantation and all infected or disease 
embryos are discarded. As a result, couples are not faced with the problem of aborting the fetus 
later on during prenatal testing if a genetic condition is detected.
41
 Therefore, some view PGD as 
an ethical alternative to termination of a pregnancy.
42
 
The benefits of PGD can be observed in the example of Jeffrey and Melanie Sowers, a 
California couple whose first child was diagnosed with a form of muscular dystrophy.
43
 Couples 
like the Sowers use PGD to avoid the chance of passing genetic diseases, like muscular 
dystrophy, on to any future children.
 44
 Before giving birth to their second child, the Sowers used 
PGD to detect genes that carry the genetic disease and then used IVF technologies to implant the 
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unaffected embryos that were not carriers for the disease into Mrs. Sowers.
 45
 This way they were 
guaranteed to give birth to a child unaffected with muscular dystrophy. 
Another couple, the Dunthores, gave birth to a child with cystic fibrosis, who died a few 
months later.
46
 The couple was originally unaware they were carriers for the disease and feared 
that they would give birth to another child who would suffer from cystic fibrosis.
 47
 The couple 
decided to use PGD to have their embryos tested.
 48
  Embryologists tested the cells for the cystic 
fibrosis gene.
 49
  Those that were affected with cystic fibrosis were discarded. Those that were 
unaffected were placed in the uterus.
 50
 Eventually, Susan gave birth to a child unaffected with 
cystic fibrosis.
 51
   
As you can see in the two examples above, PGD is a beneficial alternative for couples 
that are carriers for genetic diseases. Often times these couples may be forced to remain 
childless, may question adoption, or even sometimes endure the stress of terminating the 
pregnancy. However, now these at-risk couples are provided with alternatives due to the benefits 
of PGD. These parents who undergo PGD treatment no longer need to worry that their children 
will be born with a genetic condition and have to undergo years of testing and monitoring, 
treatment, or even death. 
B. Late Onset Genetic Diseases 
PGD can also be used to prevent late onset diseases including Alzheimer’s, Huntington’s 
disease and potentially even cancer.
 52
 Many late onset diseases include an inevitable process of 
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slow mental and physical deterioration, which eventually leads to death. PGD could prevent the 
birth of children with late onset diseases who would spend their lives being closely monitored, 
having to undergo multiple surgeries and other preventive measures or dying as a result of the 
disease.
53
 PGD provides parents with a sense of security knowing their children will not spend 
their adult lives suffering from a genetic condition. 
The Kingsbury’s story illustrates the benefits of using PGD in regards to late onset 
genetic conditions. The Kingsbury’s are a couple that lost his mother, her father and her two 
brothers, all to an inherited form of colon cancer.
 54
  Therefore, they decided to conceive their 
child using PGD technology to ensure the child would never have to suffer from colon cancer.
55
 
The Kingsbury’s used PGD to detect a predisposition to colon cancers that may or may not have 
developed later in their child’s life. 56 PGD allowed the Kingsbury’s to give birth to a baby girl 
who will grow up be unaffected by colon cancer.
 57
   
The ability to prevent late onset diseases serves an important function for society and 
would greatly decrease the population of people who become ill. However, many question if as a 
society we should have the right to say that embryos that suffer from genetic conditions do not 
deserve to be born. Especially, since many times people born with late onset diseases can live 
very fulfilling lives for a long period of time. Therefore, an ethical dilemma exists whether 
reproductive medicine should prevent a child from being born who will only become ill toward 
the end of their lives. Society must decide whether the desire to prevent suffering that is not 
certain to occur justifies the conscious destruction of an embryo that carries the defective gene.
58 
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There are benefits of using PGD exclusively for medical purposes to select against 
serious or life-threatening genetic conditions. At this time PGD has been utilized for selection 
against medical traits. PGD has been used for implantation of embryos based on gender 
preferences. However, many people are horrified by the thought of potential parents being able 
to select their children’s genes for cosmetic trivial traits. The prospect of PGD for “unnatural 
selection” or selection of cosmetic, non-therapeutic traits is the subject of numerous debates. 
III. Ethical Arguments Regarding Genetic Enhancement 
To date, PGD has only been used to treat serious, life-threatening genetic conditions and 
in some cases sex selection. However, as technology advances, the possible uses for PGD begin 
to move towards selecting for a trait instead of selecting against a genetic condition. Currently, 
technology makes it possible to select gender, and soon it will be able to select for appearance, 
personality, and IQ. Some believe that parents will inevitably want to choose their children’s 
genes, thus creating designer babies. As the potential uses for PGD technology expands so do the 
ethical and social concerns. Often, these non-therapeutic uses of PGD for selection of sex, 
cosmetic traits or performance traits are referred to as “positive eugenics” or “non-therapeutic 
enhancement.” 59   Unlike therapeutic uses for PGD, non-therapeutic enhancement offers parents 
the hope of using embryonic genetic therapy to create children with attributes likely to improve 
their chances for a “fruitful and rewarding life”.60 However, simply because technology makes it 
possible the question still remains whether or not potential parents should be given the right to 
alter their children’s genes according to their own preference and liking. By affording parents 
this right it raises many social, ethical and legal questions.  
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A. Sexism and its Affects on Altering the Population  
Recent advances in ART provide parents with an accurate method of selecting the sex of 
their children prior to conception.
61
 Proponents of this technology argue that families are simply 
seeking a balance.
62
 However, rejecting a boy or girl when there is no medical need seems 
morally reprehensible. Discarding an embryo simply based on its sex is an entirely new form of 
sex discrimination. There is also a concern that this type of genetic selection is all too similar to 
forms of selective abortion, which are still being practiced in societies like China or India.
 63
  
Both of those countries condone the killing of female embryos because they are the undesirable 
sex. These countries have long practiced infanticide, where infants are suffocated shortly after 
birth, or have used selective abortions to terminate female fetuses.
64
 In an attempt to avoid such 
scenarios, many countries have implemented types of regulation saying after you have “x” 
number of children that are one gender you can use PGD to make sure you have a child of the 
other gender.
 65
  However, the ethical question remains what number should “x” be.  
For example, a California woman with three sons used PGD because she wanted to 
ensure her next pregnancy was a girl.
66
 After three children all of the male sex, she was able to 
use PGD to select for female embryos. Many parents similar to this California woman all state 
that their motives are part of their desire to have a “balanced family.”67 This term is used to 
describe families that have children of all one sex and desire their last child to be of the opposite 
sex.
68
 The argument of family balancing seems to be a weak one; you are not really balancing 
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anything at all but rather sexually discriminating against one gender and discarding an otherwise 
healthy embryo.
69
 
Sex selection has also sparked debate over whether parents' procreative freedom to 
choose their child's gender outweighs society's greater concern regarding gender stereotypes and 
equality.
 70
 
 
Proponents argue families should be entitled to select embryos of the desired sex.
71
 
However, sex selection would contribute to sex ratio imbalances, and would only reinforce 
sexism toward women. Over time sex selection will lead to a changed sex ratio, with fewer 
women than men, thus leading to inequality for women.
72
 It is speculated that selection for a first 
child would favor males, which if executed on a large scale could lead to great disparities in the 
sex ratio of the population.
73
 Sex selection is essentially sex discrimination. 
B. Autonomy  
In reality parents already possess a high degree of control over the outcome of their 
children’s lives. If technology continues to progress to allow such intense preimplantation 
manipulation it would be irresistible for parents who could afford this technology to give their 
children a genetic head start.
74
  The important question that arises is whether there is really an 
ethical distinction between being able to paying for the best coach for your child or the best SAT 
tutor and simply being able to pay for that desired trait of athleticism or intellect. Providing 
coaches and tutors is simply considered as parents doing what is best for their children; all 
parents want to give their children the best life and provide them with the most advantages. 
However, there is a difference between paying for the gene for your child to be musically 
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inclined versus signing them up for music classes or taking them to concerts on a regular basis. 
Now being the best parent means you have genetically engineered your child to perfection.  This 
is very problematic for society and a very slippery slope. However, in today’s society where 
colleges and little league games are so competitive it is a very appealing option that can be easily 
taken advantage of. And the irony of the situation is those parents who do not take advantage of 
PGD technology will be viewed as the neglectful or bad parents. 
75
 
Many advocates argue that it is the parent’s right to equip their children with certain traits 
and provide them with the tools to be successful in life. 
76
 The children who were genetically 
engineered will most likely have a tendency to achieve more than their “unenhanced cohorts.”77 
Although it may be parent’s right to provide their children with the opportunity to succeed, 
children’s futures may be harmed by parent’s pre-birth intervention. Genetic engineering may 
eventually allow parents to choose cosmetic, intellectual, and physiological enhancements for 
their child before the child is even born. In reality, it is impossible for a parent to know entirely 
what is best for a child before they are born. There are simply too many factors science cannot 
take into consideration. Parents are unable to know that providing their child with the skills to be 
musically inclined is in fact what is best for the child. Parents are unable to predict that just 
because they provide their child with the genes to be a great athlete that their child will enjoy 
sports. Parent providing their child with these hand picked genes have no idea if they will 
actually benefit their child. Therefore, any decisions to provide genetic enhancements for a child 
is only motivated by life choices that the parents themselves have chosen.
78
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Parental autonomy is the liberty to decide for their children what the parents judge is best. 
However, we must question what would happen if parental autonomy goes too far. It would seem 
at some point society would begin to lack free choice. Genetic enhancements would make it 
impossible for a child to determine their own success or decide what would make them happy.
79
 
Everything would be predetermined for them before birth. A child would be unable to practice an 
instrument or play a sport unless their parent had specifically paid for that gene. Eventually, a 
child may be forced to become a musician because his or her parents paid for the musicality 
gene, when in fact the child would have rather been an athlete. At some point children will resent 
their parents for having made them this way.
80  
An additional concern is that parents who have engaged in cosmetic genetic 
enhancements will be unable to accept their children as they are and these parents will be “less 
tolerant of imperfections and deviations from the norm.”81 Eventually this lack of tolerance will 
lead to parents imposing an absurd about of pressure on their child to be perfect. Or expect their 
children to excel in the traits the parents have genetically enhanced. For example, if the child is 
born with enhanced intelligence the child may feel compelled to perform exceptionally well in 
school.
82
 The parent-child relationship changes into one where the child is conceived to fulfill 
the parental expectations that the parents have chosen and paid for.  
Thus, parents will begin to place excessive expectations on their customized children, 
their designer products.
 83
 PGD will increase intolerance of imperfections and as a result parents 
will settle for nothing less than perfection. Parents may begin to harbor resentment towards the 
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child if they did not turn out how they expected them to. However, unlike other commodities, a 
designer baby is not returnable.  
C. Legal Liability Claims 
Designer children create a culture of consumerism. You pay for a trait, and you expect 
that trait. Allowing parents to have the ability to select the best embryos and the best traits for 
their children will lead to the commodification of children.
84
 “Consumer-driven parents may feel 
as though they paid for a perfect child and that anything less than perfect would be 
unacceptable.”85 For example, you purchase the gene for athleticism but your child or your 
product is not athletic, in fact far from athletic, your child is clumsy. Now the parents, or the 
consumers, are upset, and rightfully so since they did not get what they paid for. When your 
customized child does not meet your expectations, there is unfortunately no return policy.  
In a society where lawsuits are so common, this commodification of children may give 
rise to product liability issues. In reality, PGD technology is not perfect. Mistakes in diagnosis 
have occurred. In these circumstances, wrongful birth lawsuits emerge, as do issues of medical 
malpractice and professional negligence.  “Wrongful birth” claims are brought by parents 
alleging that, but for the defendant’s negligence, they would have aborted or never conceived the 
child.
86
 “Wrongful life” claims are those brought by the unhealthy child alleging that, but for the 
defendant’s negligence, they would not have been born.87 In cases like these claims for wrongful 
birth and wrongful life would be brought against the physicians who performed PGD testing, and 
hospitals or medical practices that employed such physicians. These parents would claim 
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damages asking for reimbursement for the costs of all the PGD treatments, as well as the future 
cost of bearing and rearing a child with a genetic condition.  
Courts have addressed a variety of cases relating to assisted reproduction, but only a few 
concerning PGD. For example, in Doe v. Illinois Masonic Med. Ctr.,
88
 parents sued the 
institution where they underwent PGD treatment after their child was born with cystic fibrosis. In 
that case, the parents' claimed a “loss of consortium” and “wrongful life” claim on behalf of the 
child.
 89
 Although in that case the court rejected both claims concluding that the defendants could 
not be held legally liable, future scenarios may prove successful.
 90
  
In Doolan v. IVF Am. (MA), Inc.,
91
 the parents of a child born with cystic fibrosis 
following PGD, as well as the child, sued those involved with the embryo screening for failing to 
detect the condition.
 92
 The parents made the claim of “loss of consortium,” meaning the loss of 
the companionship they would otherwise have had with a healthy, non-affected child.
 93
 The 
court rejected this claim reasoning that defendants were not legally responsible for causing the 
child to suffer from a genetic disease.
 94
 The court also rejected the child’s claim of “wrongful 
life,” which alleged that the defendants’ negligent failure to detect the genetic condition denied 
his parents an opportunity not to give birth to him.
 95
 Most courts reject such wrongful life claims 
because otherwise courts would be accepting the proposition that there can be instances in which 
an impaired life is worse than no life at all.
96
 In the future PGD may give rise to product liability 
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cases where parents begin to sue doctors for fraud, misrepresentation, or false advertising. It 
would seem the possibilities are endless. 
Not only could parents and children have claims against their providers, children may 
have claims against their parents. Using PGD, parents could intentionally choose embryos with 
disabilities. Parents may select genetic traits that run in the family for example traits such as 
deafness or Achondroplasia (dwarfism).
97
 Parents would argue that they are better suited to 
handle children who are more like them. If this is the case children maybe able to hold their 
parents liable in tort for making genetic decisions that disfavored them.
98
 Children would be able 
to sue their parents for engaging in certain direct genetic interventions. Parents' preimplantation 
genetic choices would limit a child's ability to pursue a variety of different life paths and tort law 
would protect a child's moral right to an open future.
 99
 
D. Distributive Justice 
The social argument against designer babies is that if this technology becomes a realistic 
and accessible medical practice, then it would create a division between those that can afford the 
service and those that cannot. Using PGD to screen for non-medical traits could cause further 
division between the wealthy and the poor.
100
 The poor will face further disadvantages because 
they cannot afford the procedure.
101
 As it is, wealthier individuals already possess social 
advantages such as “money, status and access to information concerning new 
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biotechnologies.”102 The advantages of PGD technology will eventually lead to an “even wider 
gap between the haves and the have nots.”103 
Over time, affluent parents may have children who are less prone to disease. Wealthy 
parents may be able to select traits for happiness, creativity and physical talents, while disorders 
such as obesity, heart disease, alcoholism and mental illness will be left to those who are not 
genetically enhanced.
104
 Now not only is there monetary distinction between the wealthy and 
those of lower socioeconomic standing but these groups of people now have genetic distinctions. 
The upper classes’ ability to manipulate embryos preimplantation will circumvent the natural 
process of evolution. If PGD continues to only be used by the wealthy it would appear that the 
two different economic classes could grow into two different races. Genetic engineering would 
eventually result in “biological divergence and social polarization.”105 Molecular biologist Lee 
Silver, as well as many others, fear that “disparate access to genetic technologies will drive a 
wedge between enhanced and unenhanced classes of people, which will live in segregated social 
worlds where there is little chance for contact between them.” 106  
E. Discrimination  
Genetic engineering may result in fostering prejudice and stereotypes.
107
 If PGD is 
continually utilized to select for the genetic trait of height, subconsciously people will begin to 
have biases for short people, the “undesirable trait.” And now it would be obvious to the naked 
eye whom the wealthy and elite members of society. This technology would create an entirely 
new type of discrimination. The ability to choose desirable genetic traits will unintentionally 
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result in the devaluing those persons without those traits or a belief that those individuals are 
abnormal.
 108
 Inevitably, PGD technology will lead to discrimination against those who do not 
have the opportunities to utilize gene selection technologies. 
109
 
PGD may also change social attitudes toward those who are born with genetic diseases.
110
 
As a result of PGD technologies, fewer people with disabilities are born.
 111
 This will affect how 
society views those who are disabled. If fewer people are born with disease society will have a 
reduced need to find cures for genetic conditions.
 112
 Another concern is that where there are 
fewer people who suffer from certain conditions, their voices are less likely to be heard.
 113
 The 
number of individuals born with diseases will be drastically limited, it will no longer be 
important for society to look for cures or for health insurance to pay for their care. PGD 
technology will also cause discrimination against those who are disabled and create the notion in 
society that those who are disabled are not worthy of even being born.  
After enough time using this technology to select for genetic traits, PGD has the ability to 
wipe out certain traits entirely. If certain traits are widely disfavored, over time this will lead to 
fewer people with those traits, resulting in a lack of diversity.
 114
 This could lead to a type to 
genetic elimination. If over time the trend is to always choose a child with blonde hair and blue 
eyes, then eventually brown haired and brown-eyed children will no longer exist.  
Over time, perfectly healthy embryos will be destroyed based on dislike for certain traits. 
The resulting lack of diversity will be problematic. It will create a society that is intolerant to 
those who are different. As such traits or disabilities become more rare, societies lack of 
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experience with these traits will increase our ignorance towards individuals who have those 
traits.
115
 The ultimate fear is that such intolerance towards those traits will reinforce the 
prejudices against these traits and eventually the trait will become extinct entirely. Obviously this 
is not an immediate concern of PGD technology, but is still one that needs to be taken into 
consideration for the drastic effects it could have on the future.  
The ethical, social and legal concerns regarding the expansion of reproductive medicine 
demonstrate the necessity for oversight by the United States government. At present, neither 
state nor federal law regulates ART. It is critical to consider the ethical implications of PGD 
before it becomes possible to select for specific genetic traits. A lack of regulation may lead to 
unethical applications and unforeseen consequences. Therefore, governmental oversight is 
necessary.  
IV. Oversight of Designer Babies  
There is currently very little oversight of PGD in the United States. Most often decisions 
regarding PGD are left to patients and healthcare providers, who, together determine if PGD is 
appropriate in particular situations.  At the rate technology is progressing the government can no 
longer allow PGD regulation to be at the discretion of couples and their individual medical 
providers. Even though the ability to fully customize children may still be years away, it is 
important that the government realize that these technologies could vastly impact society and 
there are numerous ethical concerns that need to be addressed.  
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A. Lack of United States Oversight 
Currently, ART is largely unregulated in the United States.
116
 The government typically 
does not regulate the practice of medicine.
117
 There are a variety of mechanisms that 
governmental agencies use to regulate the safety and efficiency of health care services including 
safety requirements, reporting requirements and oversight of clinical research.
118
 However, PGD 
as a scientific process does not fall into these categories. At this time the government does not 
currently regulate PGD nor does any governmental body issue ethical recommendations.
119
 
However, it is critical to consider both the ethical and social implications of PGD technology 
discussed in Part III.
120
 As PGD technology becomes more accessible to the public, a lack of 
regulation may lead to unethical applications and unforeseen consequences.
121
 
The United States is one of the few countries that lacks PGD oversight. Germany, Austria 
and Italy have a strict statutory ban on all PGD uses.
122
 A complete ban can be justified by strong 
moral concerns about the status of the embryo.
123
 A ban is grounded on the premise that the right 
to life is the most important, therefore performing PGD is unacceptable because will result in the 
destruction of those embryos that carry disease-linked genes.
124
 A strict statutory ban however is 
not necessarily related to the ethical concerns surrounding PGD but rather focuses on the status 
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of the embryo.
 125
 A strict ban allows protection for stored or discarded embryos after genetic 
testing.
 126
 However, total prohibition seems to be neither a viable option nor an intelligent one 
since PGD has many benefits to society, which should be recognized and utilized.
 127
 
The United Kingdom and France require a clinic to obtain a license before it can perform 
preimplantation testing.
 128
 In the United Kingdom, preimplantation testing is regulated by the 
Human Fertilisation and Embryology Act 1990 (HFE Act), which requires any clinic that creates 
embryos to obtain a license.
129 Under the HFE Act, any person who “brings about the creation of 
an embryo, or keeps or uses an embryo, except in pursuance of a license is criminally liable.”130 
Additionally, criminal liability attaches to any person who knowingly or recklessly provides 
false or misleading information in order to obtain a license.
 131
 The HFE Act also established the 
Human Fertilization and Embryology Authority (HFEA), which issues licenses to clinics.
132
 The 
HFEA's purpose is to safeguard the interests of patients, children, the general public, doctors, 
service providers, the scientific community, and also future generations, as well as regulate the 
storage of embryos. HFEA also issues a Code of Practice, which requires clinics to submit a new 
application to HFEA for each new condition they want to test for and for each new test they want 
to use.
133
 The premise of the United Kingdom’s system is by making licenses very limited in 
scope, HFEA maintains substantial control over the use of PGD.
134
 Currently, the United 
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Kingdom does not allow gender selection for non-therapeutic purposes.
135
 However, HFEA 
allows tissue-typing (HLA matching) for the creation of savior siblings, subject to strict criteria. 
Other countries have taken a more moderate approach to PGD. For example, both the 
Netherlands and Australia only allow PGD for “serious conditions.” 136 However, drafting such 
guidelines may be difficult due to the ambiguity of words like “serious.” Thus, attempts to draft 
regulatory guidelines may suffer from ambiguous or uncertain language and the difficulty of 
trying to interpret such language.
137
 
Some countries like Japan or New Zealand regulate through guidelines issued by 
professional organizations.
 138
 Both countries have implemented professional organizations that 
are responsible for establishing guidelines and reviewing ethical concerns before issuing licenses 
to use PGD.
139
 Presently, there are two professional organizations in Japan, the Japan Society of 
Obstetrics and Gynecology (JSOG) and the Japan Society of Fertility and Sterility (JSFS), which 
have issued guidelines concerning many ARTs, including IVF, embryo transfer, and PGD.
140
 
Approval for the use of PGD must be sought through application to the JSOG and the guidelines 
require that PGD only be applied to “serious hereditary disorders.” 141 Failure to abide by any of 
these guidelines may result in the withdrawal of a clinic's membership in the organization. 
B. CDC Reporting 
The Centers for Disease Control (CDC) is a federal agency under the Department of 
Health and Human Services that protects the public health and safety through the control and 
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prevention of disease, injury, and disability.
142
  Congress enacted the Fertility Clinic Success 
Rate and Certification Act (FCSRCA) in 1992 mandating that all ART clinics report success rate 
data to the federal government.
143
  Currently, this is the only mechanism for reporting of ART 
use in the United States.
144
 FCSRCA requires clinics performing ART to annually provide data 
for all procedures performed to the CDC.
145
 The CDC is required to use the data to report and 
publish clinic-specific success rates and certification of embryo laboratories.
 146
  
Specifically, FCSRCA requires clinics that provide IVF services to report pregnancy 
success rates annually to the federal government.
147
 The FCSRCA requires clinics to report data 
concerning the type of ART used, the medical diagnosis leading to IVF treatment, the number of 
cycles of IVF attempted, whether fresh or frozen embryos were used, the number of embryos 
transferred in each cycle, the number of pregnancies achieved and the number of live births.
 148
  
However, FCSRCA does not require clinics to report the health status of babies born as a result 
of the procedure or the use of diagnostic tests such as PGD.
 149
 
Under the FCSRCA, CDC developed a model state program for certifying laboratories 
that work with human embryos.
150
 It includes standards for procedures, record keeping and 
laboratory personnel and criteria for inspection and certification.
151
 However, the model program 
is voluntary and has yet to be adopted or implemented by any state.
 152
  To actually be beneficial 
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and prevent the abuse of ART, the reporting requirements would need to be greatly improved. 
Therefore, currently all US oversight starts and ends with reporting requirements. 
C. Reproductive Liberty 
The biggest obstacle for having a uniformed system of oversight regarding ART is the 
constitutional limitations of parental autonomy and first amendment liberties. The concern is that 
US oversight would restrict fundamental liberties including invasion of privacy and procreative 
autonomy.
153
 Determining whether a parent's choice for PGD is ethical relies heavily on whether 
the Supreme Court of the United States has interpreted a protected fundamental right for PGD.
154
  
In Eisenstadt v. Baird,
155
 the Court's held the Massachusetts law prohibiting the use or 
distribution of contraceptives to unmarried individuals unconstitutional.
 156
 The Court reasoned 
that the Massachusetts law violated the Equal Protection Clause of the Fourteenth Amendment, 
and was therefore unconstitutional.
 157
 The Court made the statement that “if the right of privacy 
means anything, it is the right of the individual, married or single, to be free from unwarranted 
governmental intrusion into matters affecting a person’s decision whether to bear a child.” 158 
The Supreme Court has made it clear that parenting decisions “concerning education, 
religion, and procreation
 
are constitutionally protected interests because they involve the most 
intimate and personal choices a person can make.
159
 For example, in Planned Parenthood of Se. 
Pennsylvania v. Casey,
160
 the Court revisited the boundaries for the circumstances under which 
the State could limit the fundamental right of a woman to terminate her pregnancy as decided in 
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Roe v. Wade.
161
 The Court noted that the constitutional protection to personal decisions, such as 
procreation, family relationships, and child rearing, “involve the most intimate and personal 
choices a person may make in a lifetime, choices central to personal dignity and autonomy, are 
central to the liberty protected by the Fourteenth Amendment.”44 
In Lawrence v. Texas
162
 the Court again held that “personal autonomy is a core liberty 
interest at the heart of the due process clause.” 163 Regarding the constitutionality of a Texas 
statute criminalizing the intimate sexual conduct of two members of the same sex, the Court held 
that under the Due Process Clause of the Fourteenth Amendment the Texas statute was 
unconstitutional for violating the privacy liberty of individuals in making a decision about their 
sexual practices.
 164
 In Lawrence, the Court expanded protected privacy rights associated with 
personal choices. Therefore, Lawrence, creates the possibility of a broader interpretation into 
reproductive rights involving genetics in ART.
 165
 
In Washington v. Glucksberg,
166
 the Court downplayed the role of autonomy stating “that 
many of the rights and liberties protected by the due process clause sound in personal autonomy 
do not warrant the sweeping conclusion that any and all important, intimate, and personal 
decisions are so protected.” 167  
In fact the Supreme Court has already determined in Maher v. Roe, that a woman has a 
fundamental reproductive right to decide when to have a child.
 168 
 The court stated a woman has 
a reproductive right of “procreation without state interference,”169 This includes the right to 
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decide when to get pregnant, and the right to terminate a pregnancy.
 170   
However, the Supreme 
Court has not recognized that the rights of procreative liberty and family discretion extend so far 
as to protect all parental decisions relating to preconception selection.
 171
 Therefore, procreative 
liberties may not extend towards genetic testing, screening and manipulation. Especially since 
the ethical concerns that face prenatal genetic manipulation are different from fundamental 
reproductive rights. As a result regulations dealing with these ethical concerns would not be 
unconstitutional.  
Additionally, the Supreme Court could easily find a compelling state interest in 
regulating the health and safety of embryos and their mothers. The state has an interest in 
regulating PGD procedures to the extent that they are motivated by and promote 
discrimination.
172
 The state could also regulate prenatal technologies using its police powers to 
the extent that prenatal procedures will be harmful to public welfare or health.
173
 Therefore, 
federal oversight is constitutional.   
D. The Need for National Oversight  
The current system is decentralized and lacks regulation.
174
 The most effective way to 
regulate PGD would be at the federal level, because such a system provides the most 
uniformity.
175
 A nationwide approach would likely lead to the most uniform regulation, thereby 
minimizing delegating state legislatures competing for medical tourism by enacting minimal 
regulations to attract patients seeking PGD treatment.
 176
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National oversight can be imposed either by federal legislation or through professional 
organizations.
 177
 Oversight performed on a nationwide level by a statutorily created body with 
legal authority to attach criminal liability to violators of the statute, would provide the benefits of 
uniform regulation, flexibility, and compliance with regulatory guidelines.
 178
 A licensing system 
similar to that of the United Kingdom's would strike a balance between ethical concerns and the 
progress of science and medical technology.
 179
 Violations of the statutory licensing system could 
include administrative measures such as suspension or termination of licenses or a prohibition on 
a clinic's ability to receive licenses in the future, or criminal punishments such as fines or 
imprisonment.
 180
 Professional organizations present another opportunity for oversight of PGD. 
Professional organizations are comprised of members of a particular occupation or specialty, 
therefore they have more specialized expertise.
181
 Most importantly, professional organizations 
can develop and amend guidelines much faster than legislatures, which is particularly important 
in an area of rapidly advancing technology such as PGD.
182
 
D. Professional Oversight  
Medical and scientific professional organizations have the best opportunities to collect 
data and interact with patient groups based on this knowledge they have the ability to consider all 
ethical concerns and determine the acceptable uses for PGD.
 183
 Professional organizations can 
educate members about advances in the field, develop guidelines addressing appropriate conduct 
and impose standards of adherence that are a prerequisite for membership.
 184
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A few professional organizations already have the relevant expertise and either currently 
or could in the future develop PGD-specific guidelines or standards.
185
   For example, the 
American Society for Reproductive Medicine (ASRM) is a professional organization whose 
members are health professionals engaged in reproductive medicine.
186
 ASRM issues policy 
statements, guidelines and opinions regarding medical and ethical issues that reflect the thinking 
of the organization’s various practice committees. 187  In fact, ASRM has already warned patients 
to be aware of potential diagnostic errors and the possibility unknown long-term consequences c 
of PGD.
188
 ASRM has also issued an ethics committee opinion cautioning against the use of 
PGD for sex selection in the absence of a serious sex-linked disease.
 189
   
Another Professional Organization is the Society for Assisted Reproductive Technologies 
(SART).
190
 SART administers the legislatively mandated reporting requirements for fertility 
clinics and then collects this data, which is then analyzed and reported by CDC.
 191
 Compliance 
with the reporting requirements and guidelines is a requirement of SART membership.
192
 
However, at this time the organization does not have any guidelines specifically addressing 
PGD.
193
  
Centers for Medicare and Medicaid Services (CMS) implemented the Clinical Laboratory 
Improvement Amendments of (CLIA) in 1988.
194
  CLIA was enacted in order to improve the 
quality of clinical laboratory services.
 195
  CLIA includes requirements addressing laboratory 
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personnel qualifications, documentation and validation of tests and procedures, quality control 
standards and proficiency testing to monitor laboratory performance.
 196
  However, CMS has not 
taken a position regarding whether laboratories engaged in IVF and PGD are “clinical 
laboratories” within the meaning of the statute. 197 However, many argue since IVF and PGD are 
procedures that constitute the practice of medicine they are not within the scope of CLIA.
 198
    
Other professional organizations that do not currently address PGD could take on 
additional functions in the future. The PGD International Society (PGDIS), was recently founded 
to promote PGD and to organize meetings and workshops on PGD research.
 199
  The College of 
American Pathologists (CAP) has developed a voluntary certification program for reproductive 
laboratories that perform embryology testing and inspects clinical laboratories seeking 
certification under CLIA.
 200
 American College of Medical Genetics (ACMG) develops 
laboratory standards and clinical practice guidelines for genetic tests.
 201
  
The health and safety of women and children who use ART technologies is paramount to 
these professional organizations. Professional oversight has the ability to monitor the safety, 
efficacy and privacy guidelines associated with ART technologies. The organization can issue 
guidelines that make the distinction clear between what constitutes a serious genetic condition 
and what does not. The organization can limit PGD to medical uses and determine the acceptable 
uses of PGD.
202
 Therefore, the government can state that PGD should only be used if the 
condition constitutes serious or significant genetic condition.  
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Regulation through professional organizations may be difficult because of a lack of 
consequences for violating guidelines.
203
 Professional organizations typically do not have 
authority to sanction members for noncompliance. Generally, the only consequence of non-
compliance with guidelines is the revocation of a clinic's membership, and the organization.
 204
  
Unless the organization is specifically authorized by the federal government to act on the 
government’s behalf in administering and enforcing government standards, actions of the 
professional organization do not have the force of law.  
E. Proposed Solution 
The ethical concerns surrounding PGD suggest that oversight is needed, and PGD should 
be regulated through guidelines issued by professional organizations.
205
 The professional 
organizations would be composed of PGD providers. Therefore, these groups would know the 
most about the use, limitations, risks and benefits of PGD. Through collections of data from 
interaction with patient groups, ongoing studies of children born with PGD, public opinion, and 
feedback from those already affected with genetic diseases and disabilities, information can be 
used to assess the risk and benefits associated with PGD.
 206
 Through a new or existing 
professional society could create guidelines for acceptable uses of PGD faster than legislatures, 
which is important in such a rapid growing field.  
Ethical concerns should be taken into account in issuing licenses and guidelines. 
However, these concerns need to be balanced against the interest of not foreclosing the 
advancement of technology, since PGD has the potential to greatly benefit society through the 
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reduction of genetic disorders.
 207
 The professional organization would be able to correctly 
balance these dilemmas for the greater good of society. This approach provides the most 
flexibility for the development of science and technology. Additionally, by utilizing a 
professional organization, it avoids government intrusion in medical practices.  Failure to abide 
by the guidelines ideally need to result in stricter punishments in order to increase compliance.  
Conclusion 
It is clear there is a need for oversight by the United States government in regards to 
PGD. Although parents may be morally and legally entitled to use PGD for customization of 
their children as part of the parental autonomy, as technology continues to advance we need the 
government to implement regulations to ensure risks of these advancements never outweigh the 
benefits. Without proper oversight children become products to be bought and sold. Without 
proper oversight the ethical and social concerns discussed could become a reality. In order for 
the necessary oversight to be functional the government should enlist or create a professional 
organization that has the ability to ensure that PGD and other prenatal technologies can only be 
used for medical purposes, and issue strict punishments for those who fail to comply.  
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